rivastigmine has been researched along with Psychomotor Agitation in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (80.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SH; Han, HJ; Kim, EJ; Lee, JH; Na, DL; Na, HR; Park, KW; Shim, YS; Yoon, SJ | 1 |
Osborn, GG; Saunders, AV | 1 |
Alagiakrishnan, K; Robertson, D; Sclater, A | 1 |
Kaufer, DI | 1 |
Ballard, C; Bannister, C; Douglas, S; Elvish, R; Everratt, A; Jacoby, R; Juszczak, E; Lee, L; Maddison, C; Margallo-Lana, M; O'Brien, J; Sadler, S; Swann, A; Thomas, A | 1 |
Ownby, RL | 1 |
Clare, C; Dean, C; El-Okl, M; Hensford, C; Holmes, C; Moghul, S; Wilkinson, D | 1 |
Baik, J; Han, IW; Koo, MS; Kwak, YT | 1 |
Caffarra, P; Godani, M; Majer, S; Paolello, P | 1 |
Byrne, EJ; Collins, CC; Maclean, LE | 1 |
1 review(s) available for rivastigmine and Psychomotor Agitation
Article | Year |
---|---|
Current treatments for patients with Alzheimer disease.
Topics: Aggression; Alzheimer Disease; Behavior Therapy; Cholinesterase Inhibitors; Depression; Excitatory Amino Acid Antagonists; Galantamine; Health Status; Humans; Memantine; Neuroprotective Agents; Parasympathomimetics; Phenylcarbamates; Psychomotor Agitation; Psychotherapy; Psychotic Disorders; Rivastigmine; Time Factors; United States; United States Food and Drug Administration | 2010 |
4 trial(s) available for rivastigmine and Psychomotor Agitation
Article | Year |
---|---|
Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Alzheimer Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Follow-Up Studies; Humans; Male; Memantine; Multivariate Analysis; Prospective Studies; Psychomotor Agitation; Republic of Korea; Risk Assessment; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome | 2017 |
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Dibenzothiazepines; Double-Blind Method; Humans; Middle Aged; Phenylcarbamates; Psychomotor Agitation; Quetiapine Fumarate; Rivastigmine; Treatment Failure | 2005 |
Quetiapine and rivastigmine for agitation in Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Dibenzothiazepines; Disease Progression; Double-Blind Method; Humans; Phenylcarbamates; Psychomotor Agitation; Quetiapine Fumarate; Rivastigmine | 2006 |
Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
Topics: Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Phenylcarbamates; Psychomotor Agitation; Risperidone; Rivastigmine | 2007 |
5 other study(ies) available for rivastigmine and Psychomotor Agitation
Article | Year |
---|---|
Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman.
Topics: Aged; Aggression; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Dementia, Vascular; Female; Geriatric Assessment; Humans; Neuroprotective Agents; Phenylcarbamates; Psychomotor Agitation; Rivastigmine; Sexual Behavior; Time Factors | 2003 |
A case study in the treatment of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galantamine; Hallucinations; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Psychomotor Agitation; Rivastigmine; Social Behavior | 2004 |
Relation between cholinesterase inhibitor and Pisa syndrome.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Dopamine Antagonists; Dystonia; Female; Humans; Indans; Memory Disorders; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Posture; Psychomotor Agitation; Risperidone; Rivastigmine; Syndrome | 2000 |
Rivastagmine-induced agitation following transient recollection of autobiographical memory.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Female; Humans; Phenylcarbamates; Psychomotor Agitation; Rivastigmine | 2001 |
Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition; Female; Humans; Lewy Body Disease; Male; Middle Aged; Phenylcarbamates; Psychomotor Agitation; Rivastigmine; Sleep; Treatment Outcome | 2001 |